• Markets
    • icon
  • Companies
BOT · ASX

Botanix Pharmaceuticals Limited (ASX:BOT)

AU$0.16

 0.0 (0.0%)
ASX:Live
06/12/2023 04:10:05 PM
HALO Ords HALO Momentum HALO Growth HALO Earnings Momentum GROWTH AUS +2
Consensus Score
/10
Recommend
Lock
Target Price
Lock
Deviation
Lock
Unlock Full Consensus Insights

BOT Overview

BOT Health Scores

Short Term

Mean Revision

Trend

Event

Halo Model

MQV

GARP

MQV Small

Valuation

Value

Consensus

Momentum

Price

Earnings

Growth

Earnings

Dividends

Quality

Capital Efficiency

Balance Sheet

About BOT

Website

Botanix Pharmaceuticals Limited

Telephone

61.8.6555.2945

Address

Level 1 50 Angove Street North Perth, Western Australia (WA) 6006

Description

Botanix Pharmaceuticals Ltd. engages in the development of therapeutics for the treatment of skin diseases. It focuses on the treatment of patients battling with acne, psoriasis, and atoptic dermatitis. The firm also develops pharmaceutical ingredient known as cannabidol, which seeks to treat epilepsy, pain, arthritis, and schizophrenia. The company was founded by Roger New and Glen Travers in 1984 and is headquartered in North Perth, Australia.

BOT Price Chart

Key Stats

Market Cap

AU$254.29M

PE

N/A

EV/EBITDA

N/A

Dividends Overview

DIV Yield

N/A

Franking

N/A

Ex Dividend Date (est.)

N/A

Market Data

52 weeks range

Low 0.05 - 0.21

Trade Value (12mth)

AU$87,819.00

1 week

-6.06%

1 month

14.81%

YTD

198.08%

1 year

158.33%

All time high

163.333

Key Fundamentals

EPS 3 yr Growth

-55.900%

EBITDA Margin

%

Operating Cashflow

-$12m

Free Cash Flow Return

-77.60%

ROIC

-58.90%

Interest Coverage

-155.20

Quick Ratio

5.70

Other Data

Shares on Issue (Fully Dilluted)

1312m

HALO Sector

Healthcare

Next Company Report Date

22-Aug-24

Ex Dividend Date (est.)

N/A

Next Dividend Pay Date (est.)

N/A

Reporting Currency

AUD

Short Sell (% of issue)

0.00

BOT Announcements

Latest Announcements

Date Announcements

31 October 23

September 2023 Quarterly Activities Report and Appendix 4C

×

September 2023 Quarterly Activities Report and Appendix 4C

31 October 23

Investor Presentation and Investor Meetings

×

Investor Presentation and Investor Meetings

31 October 22

A$5 million Institutional Placement and Share Purchase Plan

×

A$5 million Institutional Placement and Share Purchase Plan

31 October 22

Proposed issue of securities - BOT

×

Proposed issue of securities - BOT

31 October 22

Proposed issue of securities - BOT

×

Proposed issue of securities - BOT

31 October 22

Proposed issue of securities - BOT

×

Proposed issue of securities - BOT

31 July 23

June 2023 Quarterly Activities Report and Appendix 4C

×

June 2023 Quarterly Activities Report and Appendix 4C

31 January 23

Appendix 4C - Quarterly

×

Appendix 4C - Quarterly

31 January 23

Investor Presentation and Video

×

Investor Presentation and Video

31 January 19

2019 Outlook Presentation

×

2019 Outlook Presentation

31 August 23

2023 Annual General Meeting - Key Dates

×

2023 Annual General Meeting - Key Dates

31 August 23

Appendix 4E Preliminary Final Report

×

Appendix 4E Preliminary Final Report

31 August 22

Preliminary Final Report

×

Preliminary Final Report

31 August 22

Trading Halt

×

Trading Halt

31 August 20

Appendix 4E and Annual Report to Shareholders

×

Appendix 4E and Annual Report to Shareholders

31 August 16

Appendix 4E and Annual Report to Shareholders

×

Appendix 4E and Annual Report to Shareholders

30 September 13

Bone Medical Limited - Annual Report (BNE-AU)

×

Bone Medical Limited - Annual Report (BNE-AU)

30 September 11

Annual Report (BNE-AU)

×

Annual Report (BNE-AU)

30 November 22

Application for quotation of securities - BOT

×

Application for quotation of securities - BOT

30 November 16

AGM Investor Presentation

×

AGM Investor Presentation

30 November 16

Results of Annual General Meeting

×

Results of Annual General Meeting

29 September 23

Appendix 4G and Corporate Governance Statement

×

Appendix 4G and Corporate Governance Statement

29 September 23

Annual Report

×

Annual Report

29 September 09

Annual Report (BNE-AU)

×

Annual Report (BNE-AU)

29 September 06

Annual Report

×

Annual Report

29 October 12

Bone Medical Limited - Notice of Annual General Meeting/Proxy Form (BNE-AU)

×

Bone Medical Limited - Notice of Annual General Meeting/Proxy Form (BNE-AU)

29 October 10

Annual Report to shareholders (BNE-AU)

×

Annual Report to shareholders (BNE-AU)

BOT Fundamentals

Per Share Records

Historical data

Forecasted data

AUD 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026
Per Share, Growth & Valuations
EPS (Basic) $ Lock Lock Lock Lock -0.00 -0.01 -0.01 Lock Lock Lock
EPS (Fully Diluted) $ Lock Lock Lock Lock -0.00 -0.01 -0.01 Lock Lock Lock
     Growth % Lock Lock Lock Lock 81.0 -297.1 41.5 Lock Lock Lock
     PE X Lock Lock Lock Lock N/A N/A N/A Lock Lock Lock
     EV/EBITDA X Lock Lock Lock Lock N/A N/A N/A Lock Lock Lock
CFPS $ Lock Lock Lock Lock -0.00 -0.01 -0.01 Lock Lock Lock
FCFPS $ Lock Lock Lock Lock -0.00 -0.01 -0.01 Lock Lock Lock
     Growth % Lock Lock Lock Lock 81.3 -375.1 56.1 Lock Lock Lock
     Yield % Lock Lock Lock Lock -3.8 -20.2 -8.1 Lock Lock Lock
DPS $ Lock Lock Lock Lock 0.00 0.00 0.00 Lock Lock Lock
     Growth % Lock Lock Lock Lock N/A N/A N/A Lock Lock Lock
     Yield % Lock Lock Lock Lock N/A N/A N/A Lock Lock Lock
     Payout Ratio % Lock Lock Lock Lock 0 0 0 Lock Lock Lock
BPS $ Lock Lock Lock Lock 0.02 0.01 0.02 Lock Lock Lock
BPS (Tangible) $ Lock Lock Lock Lock 0.02 0.00 0.01 Lock Lock Lock
     Growth % Lock Lock Lock Lock -12.0 -76.7 86.6 Lock Lock Lock
Shares Outstanding
Diluted m Lock Lock Lock Lock 973 973 1,154 Lock Lock Lock
Basic m Lock Lock Lock Lock 973 973 1,154 Lock Lock Lock

Financial Records

Historical data

Forecasted data

AUD 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026
Income Statement
Sales $m Lock Lock Lock Lock 0 0 1 Lock Lock Lock
     Growth % Lock Lock Lock Lock N/A N/A N/A Lock Lock Lock
Selling & General Expenses $m Lock Lock Lock Lock 10 16 10 Lock Lock Lock
Gross Income $m Lock Lock Lock Lock 0 0 -3 Lock Lock Lock
     Growth % Lock Lock Lock Lock 7.9 -52.3 -2,022.6 Lock Lock Lock
     Margin % Lock Lock Lock Lock N/A N/A -332.9 Lock Lock Lock
Cost of Goods Sold to Sales % Lock Lock Lock Lock N/A N/A 433 Lock Lock Lock
EBITDA $m Lock Lock Lock Lock -10 -16 -13 Lock Lock Lock
     Growth % Lock Lock Lock Lock 57.9 -55.3 19.7 Lock Lock Lock
     Margin % Lock Lock Lock Lock N/A N/A -1,386.4 Lock Lock Lock
Depreciation & Amortisation $m Lock Lock Lock Lock 0 0 0 Lock Lock Lock
EBIT $m Lock Lock Lock Lock -10 -16 -13 Lock Lock Lock
     Growth % Lock Lock Lock Lock 57.7 -55.3 19.7 Lock Lock Lock
     Margin % Lock Lock Lock Lock N/A N/A -1,398.5 Lock Lock Lock
Pretax Income $m Lock Lock Lock Lock -10 -16 -13 Lock Lock Lock
Income Taxes $m Lock Lock Lock Lock -7 -3 -4 Lock Lock Lock
Net Income $m Lock Lock Lock Lock -3 -13 -9 Lock Lock Lock
     Growth % Lock Lock Lock Lock 80.1 -295.0 30.5 Lock Lock Lock
     Margin % Lock Lock Lock Lock N/A N/A -1,000.5 Lock Lock Lock
Cash Flow Statement
Net Operating Cash Flow $m Lock Lock Lock Lock -3 -11 -12 Lock Lock Lock
Capital Expenditures $m Lock Lock Lock Lock 0 3 7 Lock Lock Lock
Net Investing Cash Flow $m Lock Lock Lock Lock 0 -3 -7 Lock Lock Lock
Net Financing Cash Flow $m Lock Lock Lock Lock 0 0 22 Lock Lock Lock
Free Cash Flow $m Lock Lock Lock Lock -3 -11 -12 Lock Lock Lock
     Growth % Lock Lock Lock Lock 82.9 -276.0 -8.0 Lock Lock Lock
     Margin % Lock Lock Lock Lock N/A N/A -13.2 Lock Lock Lock
Franking Balance $m Lock Lock Lock Lock N/A N/A 0 Lock Lock Lock
Balance Sheet
Cash & Short-Term Investments $m Lock Lock Lock Lock 22 7 10 Lock Lock Lock
Total Assets $m Lock Lock Lock Lock 22 14 25 Lock Lock Lock
Long Term Debt $m Lock Lock Lock Lock 0 0 0 Lock Lock Lock
Net Debt $m Lock Lock Lock Lock -21 -7 -10 Lock Lock Lock
Total Liabilities $m Lock Lock Lock Lock 1 6 2 Lock Lock Lock
Equity $m Lock Lock Lock Lock 21 8 23 Lock Lock Lock
Invested Capital Lock Lock Lock Lock 21 8 23 Lock Lock Lock
     Growth % Lock Lock Lock Lock -12.6 -61.0 181.5 Lock Lock Lock
Return Ratios
Return on Assets % Lock Lock Lock Lock -15.2 -93.8 -36.9 Lock Lock Lock
Return on Equity % Lock Lock Lock Lock -16.0 -161.6 -39.9 Lock Lock Lock
Return on Total Capital % Lock Lock Lock Lock -45.5 -108.7 -82.0 Lock Lock Lock
Return on Invested Capital % Lock Lock Lock Lock -14.9 -90.6 -58.9 Lock Lock Lock
Cash Flow Return on Invested Capital % Lock Lock Lock Lock -13.2 -77.0 -77.6 Lock Lock Lock

Ratios Records

Historical data

Forecasted data

AUD 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026
Leverage
Interest Cover X Lock Lock Lock Lock -181.9 -421.9 -155.2 Lock Lock Lock
Debt to EBITDA X Lock Lock Lock Lock 2.1 0.5 0.8 Lock Lock Lock
Net Debt to Equity % Lock Lock Lock Lock -102.4 -87.9 -44.7 Lock Lock Lock
Liquidity
Current Ratio X Lock Lock Lock Lock 20.8 1.8 7.4 Lock Lock Lock
Quick Ratio X Lock Lock Lock Lock 20.8 1.3 5.7 Lock Lock Lock
Cash & ST Inv/Current Assets % Lock Lock Lock Lock 99.7 69.4 73.3 Lock Lock Lock
CFO/Current Liabilities % Lock Lock Lock Lock -286.0 -190.0 -640.5 Lock Lock Lock
Balance Sheet Efficiency
Receivables Turnover X Lock Lock Lock Lock 0.0 0.0 2.9 Lock Lock Lock
Inventory Turnover X Lock Lock Lock Lock N/A 0.1 1.3 Lock Lock Lock
Working Capital Turnover X Lock Lock Lock Lock 0.0 0.0 0.1 Lock Lock Lock
Payables Turnover X Lock Lock Lock Lock N/A N/A 152.0 Lock Lock Lock
Asset Turnover X Lock Lock Lock Lock 0.0 0.0 0.0 Lock Lock Lock
Du Pont
Asset Turnover X Lock Lock Lock Lock 0.0 0.0 0.0 Lock Lock Lock
x Pretax Margin % Lock Lock Lock Lock N/A N/A -1,401.5 Lock Lock Lock
= Pretax Return on Assets % Lock Lock Lock Lock N/A N/A -51.6 Lock Lock Lock
x Tax Rate Complement (1-Tax Rate) % Lock Lock Lock Lock N/A N/A 0.0 Lock Lock Lock
Return on Assets % Lock Lock Lock Lock -15.2 -93.8 -36.9 Lock Lock Lock
x Equity Multiplier (Assets/Equity) % Lock Lock Lock Lock 1.1 1.7 1.1 Lock Lock Lock
Return on Equity % Lock Lock Lock Lock -16.0 -161.6 -39.9 Lock Lock Lock
x Earnings Retention (1-Payout) % Lock Lock Lock Lock 100.0 100.0 100.0 Lock Lock Lock
= Reinvestment Rate (%) % Lock Lock Lock Lock -16.0 -161.6 -39.9 Lock Lock Lock
Operating Cycle
Days of Inventory on Hand Days Lock Lock Lock Lock N/A 3,871.8 285.3 Lock Lock Lock
+ Days of Sales Outstanding Days Lock Lock Lock Lock N/A N/A 125.6 Lock Lock Lock
Operating Cycle Days Lock Lock Lock Lock N/A 3,871.8 410.9 Lock Lock Lock
- Days of Payables Outstanding Days Lock Lock Lock Lock 3,543.7 305.4 272.7 Lock Lock Lock
Net Operating Cycle Days Lock Lock Lock Lock -3,543.7 3,566.4 138.2 Lock Lock Lock

Dividends

Key Stats

Ex Dividend Date (est.)

N/A

DIV Yield

N/A

Franking Level

N/A

DPSg

0.00%

Quality Yield

Lock

Falling Divs over next 2

Lock

Values and Recommendations

Key Stats

Consensus Score

Lock

Recommendation

Lock

EPS 1 month Change

Lock

Quality Yield

Lock

Falling Divs over next 2

Lock

Halo Consensus Score

Lock Chart

PEG Ratio

Lock Chart

Consensus EPS Revisions

Lock Chart

Short selling

Key Stats

Percent of Issue

0.00%

Value ($M)

0

Prior Change

N/A

7 Day Change

N/A

1 Month Change

N/A

3 Month Change

N/A

Discover
Short-selling
Opportunities

Access data on short interest, stock performance, and potential short-selling candidates across various markets to make informed decisions and optimize your trading strategies.

BOT Shortsell

Frequently Asked Questions

The current share price of Botanix Pharmaceuticals Limited (BOT:ASX) is AU$0.16.
The 52-week high share price for Botanix Pharmaceuticals Limited (BOT:ASX) is AU$0.21.
The 52-week low share price for Botanix Pharmaceuticals Limited (BOT:ASX)? is AU$0.05.
Botanix Pharmaceuticals Limited (BOT:ASX) does not pay a dividend.
Botanix Pharmaceuticals Limited (BOT:ASX) does not pay a dividend.
Botanix Pharmaceuticals Limited (BOT:ASX) has a franking level of 0%.
Botanix Pharmaceuticals Limited (BOT:ASX) is classified in the Healthcare.
The current P/E ratio for Botanix Pharmaceuticals Limited (BOT:ASX) is .
halo-logo-inverted-rgb@72ppi-1
Login
Products
Company
Important

Get the latest insights and hot tips delivered right to your inbox

Apple Store
Google Play

HALO Technologies Pty Ltd ABN 54 623 830 866 is a Corporate Authorised Representative No 1261916 of Macrovue Pty Ltd ABN 98 600 022 679 AFSL 484264. Macrovue Pty Ltd is a wholly owned subsidiary of HALO Technologies Pty Ltd.